Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
1110020P 15Rik | |
NM_197979 |
RIKEN cDNA 1110020P15 gene (1110020P15Rik), mRNA [NM_197979] |
KLA | .86 |
.91 |
.84 |
.87 |
.81 |
.87 |
1.00 |
| ATP | .95 |
.99 |
1.12 |
1.12 |
1.07 |
.94 |
.94 |
| KLA/ATP | .88 |
.87 |
1.02 |
1.02 |
1.06 |
1.02 |
1.01 |
|
AK043675
| |
AK043675 |
10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] |
KLA | 1.07 |
1.05 |
1.00 |
.98 |
1.05 |
1.02 |
1.00 |
| ATP | .92 |
1.07 |
.99 |
.93 |
1.01 |
1.01 |
1.02 |
| KLA/ATP | .96 |
.93 |
1.08 |
1.00 |
.94 |
.97 |
1.02 |
|
AK046580
| |
AK046580 |
4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430108N21 product:similar to CYTOCHROME C OXIDASE POLYPEPTIDE VA, MITOCHONDRIAL PRECURSOR (EC 1.9.3.1) [Rattus norvegicus], full insert sequence. [AK046580] |
KLA | .94 |
.93 |
.98 |
1.02 |
1.13 |
1.13 |
1.01 |
| ATP | .84 |
.93 |
.87 |
.91 |
1.14 |
1.02 |
.98 |
| KLA/ATP | .88 |
.89 |
.99 |
.92 |
1.05 |
1.05 |
.95 |
|
AK078587
| |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
Actc1 | |
NM_009608 |
actin, alpha, cardiac (Actc1), mRNA [NM_009608] |
KLA | 1.61 |
1.58 |
1.66 |
1.87 |
2.02 |
2.36 |
1.61 |
| ATP | 1.00 |
1.17 |
1.14 |
1.64 |
1.16 |
.90 |
1.01 |
| KLA/ATP | 1.67 |
1.82 |
1.77 |
2.58 |
1.70 |
1.43 |
1.33 |
|
Atp1a1 | |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
Atp1a2 | |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
Atp1a3 | |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
Atp1a3 | |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
Atp1b1 | |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
Atp1b2 | |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
Atp1b3 | |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
Atp1b4 | |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
Atp2a2 | |
NM_001110140 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 1, mRNA [NM_001110140] |
KLA | .95 |
1.07 |
.96 |
.84 |
1.17 |
1.16 |
1.53 |
| ATP | 1.16 |
1.27 |
.80 |
1.14 |
1.10 |
1.23 |
1.35 |
| KLA/ATP | 1.14 |
1.10 |
.54 |
1.15 |
.91 |
1.10 |
1.01 |
|
Atp2a2 | |
NM_009722 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 2, mRNA [NM_009722] |
KLA | .90 |
.90 |
.99 |
.96 |
1.28 |
1.09 |
1.29 |
| ATP | 1.09 |
1.12 |
.94 |
1.19 |
1.47 |
1.36 |
.98 |
| KLA/ATP | .98 |
.95 |
.72 |
1.06 |
1.44 |
1.30 |
.88 |
|
Cacna1d | |
NM_001083616 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] |
KLA | 1.57 |
1.58 |
2.50 |
3.62 |
4.55 |
2.93 |
.99 |
| ATP | 1.12 |
.99 |
.97 |
.94 |
.75 |
1.71 |
1.48 |
| KLA/ATP | 1.47 |
1.51 |
1.82 |
1.56 |
1.67 |
2.93 |
4.60 |
|
Cacna1d | |
NM_028981 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] |
KLA | 1.20 |
1.26 |
1.43 |
1.62 |
2.07 |
1.66 |
1.00 |
| ATP | 1.03 |
1.03 |
.97 |
.97 |
.93 |
1.20 |
1.26 |
| KLA/ATP | 1.16 |
1.12 |
1.10 |
1.14 |
1.08 |
1.44 |
2.56 |
|
Cacna1f | |
NM_019582 |
calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] |
KLA | 1.03 |
.98 |
1.05 |
1.06 |
1.00 |
1.02 |
1.01 |
| ATP | 1.05 |
1.05 |
.95 |
.98 |
.97 |
.96 |
1.01 |
| KLA/ATP | 1.01 |
1.03 |
.94 |
1.01 |
1.01 |
1.00 |
.99 |
|
Cacna1s | |
NM_001081023 |
calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] |
KLA | 1.03 |
1.01 |
.96 |
1.06 |
1.00 |
1.00 |
1.05 |
| ATP | 1.01 |
.98 |
1.02 |
1.02 |
1.05 |
1.07 |
1.05 |
| KLA/ATP | .99 |
1.05 |
1.02 |
1.05 |
1.03 |
1.05 |
1.00 |
|
Cacna2d1
| |
AK046959 |
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930007O16 product:calcium channel, voltage-dependent, alpha2/delta subunit 1, full insert sequence. [AK046959] |
KLA | 1.04 |
1.01 |
.94 |
.95 |
1.04 |
1.05 |
1.05 |
| ATP | 1.06 |
.98 |
.99 |
1.04 |
1.02 |
1.00 |
1.05 |
| KLA/ATP | 1.04 |
1.01 |
.99 |
1.04 |
.99 |
1.01 |
.99 |
|
Cacna2d1
| |
NM_009784 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 (Cacna2d1), transcript variant e, mRNA [NM_009784] |
KLA | 1.02 |
1.02 |
1.02 |
1.00 |
1.03 |
1.01 |
1.02 |
| ATP | .99 |
.97 |
1.07 |
1.01 |
.99 |
.97 |
1.00 |
| KLA/ATP | 1.03 |
.99 |
1.01 |
1.04 |
1.03 |
1.01 |
.92 |
|
Cacna2d2
| |
NM_020263 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 (Cacna2d2), mRNA [NM_020263] |
KLA | 1.03 |
1.04 |
1.03 |
.99 |
1.03 |
.93 |
.93 |
| ATP | 1.01 |
1.06 |
1.06 |
1.15 |
1.03 |
.99 |
.93 |
| KLA/ATP | 1.04 |
1.01 |
1.10 |
1.13 |
1.11 |
.97 |
.89 |
|
Cacna2d3
| |
NM_009785 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 (Cacna2d3), mRNA [NM_009785] |
KLA | 1.00 |
.98 |
1.07 |
.96 |
.99 |
.99 |
.99 |
| ATP | .99 |
.97 |
1.10 |
.99 |
1.00 |
.89 |
.97 |
| KLA/ATP | .95 |
1.04 |
1.00 |
.95 |
1.02 |
.99 |
.98 |
|
Cacna2d4
| |
AK030723 |
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730412N02 product:hypothetical von Willebrand factor type A domain containing protein, full insert sequence. [AK030723] |
KLA | .97 |
1.02 |
1.04 |
1.01 |
1.00 |
1.03 |
1.02 |
| ATP | 1.01 |
.93 |
1.03 |
1.01 |
.99 |
.99 |
1.01 |
| KLA/ATP | 1.03 |
.95 |
.87 |
.96 |
1.03 |
.97 |
1.05 |
|
Cacnb1 | |
NM_031173 |
calcium channel, voltage-dependent, beta 1 subunit (Cacnb1), transcript variant variant 1, mRNA [NM_031173] |
KLA | 1.35 |
1.26 |
1.13 |
1.51 |
1.54 |
1.69 |
2.10 |
| ATP | 1.01 |
1.09 |
1.16 |
1.23 |
1.39 |
1.61 |
1.34 |
| KLA/ATP | 1.20 |
1.34 |
1.81 |
1.43 |
1.62 |
1.50 |
2.03 |
|
Cacnb2 | |
AK143332 |
2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330008B16 product:calcium channel, voltage-dependent, beta 2 subunit, full insert sequence [AK143332] |
KLA | 1.18 |
1.19 |
1.17 |
1.05 |
1.03 |
1.03 |
1.03 |
| ATP | .97 |
.91 |
1.02 |
1.07 |
.95 |
1.07 |
1.03 |
| KLA/ATP | 1.20 |
1.29 |
1.16 |
1.09 |
1.02 |
1.05 |
1.03 |
|
Cacnb2 | |
NM_023116 |
calcium channel, voltage-dependent, beta 2 subunit (Cacnb2), mRNA [NM_023116] |
KLA | 1.23 |
1.15 |
1.47 |
1.25 |
1.02 |
1.02 |
1.05 |
| ATP | 1.00 |
1.01 |
.99 |
.99 |
1.02 |
1.01 |
1.01 |
| KLA/ATP | 1.21 |
1.27 |
1.12 |
1.24 |
.96 |
.98 |
1.02 |
|
Cacnb3 | |
NM_007581 |
calcium channel, voltage-dependent, beta 3 subunit (Cacnb3), transcript variant 1, mRNA [NM_007581] |
KLA | 5.88 |
5.27 |
7.39 |
5.78 |
4.94 |
2.13 |
1.26 |
| ATP | 1.03 |
1.02 |
1.22 |
1.37 |
2.49 |
2.75 |
1.61 |
| KLA/ATP | 5.92 |
6.99 |
6.43 |
6.99 |
5.42 |
3.70 |
2.61 |
|
Cacnb4 | |
NM_001037099 |
calcium channel, voltage-dependent, beta 4 subunit (Cacnb4), transcript variant 1, mRNA [NM_001037099] |
KLA | 1.07 |
1.11 |
1.17 |
1.11 |
1.15 |
1.13 |
1.07 |
| ATP | 1.00 |
1.00 |
1.03 |
1.06 |
1.21 |
1.17 |
1.50 |
| KLA/ATP | 1.13 |
1.12 |
1.15 |
1.16 |
1.35 |
1.69 |
1.32 |
|
Cacng1 | |
NM_007582 |
calcium channel, voltage-dependent, gamma subunit 1 (Cacng1), mRNA [NM_007582] |
KLA | .98 |
.93 |
.99 |
.99 |
.96 |
.99 |
1.04 |
| ATP | 1.07 |
1.40 |
2.33 |
2.01 |
1.57 |
1.10 |
1.08 |
| KLA/ATP | 1.02 |
.94 |
.98 |
1.16 |
1.07 |
.98 |
1.05 |
|
Cacng2 | |
AK047238 |
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930041E13 product:hypothetical protein, full insert sequence [AK047238] |
KLA | 1.18 |
1.18 |
1.12 |
1.11 |
1.10 |
1.17 |
1.35 |
| ATP | 1.03 |
.98 |
1.09 |
1.04 |
1.07 |
1.06 |
1.00 |
| KLA/ATP | 1.15 |
1.15 |
1.25 |
1.15 |
1.12 |
1.07 |
1.19 |
|
Cacng2 | |
NM_007583 |
calcium channel, voltage-dependent, gamma subunit 2 (Cacng2), mRNA [NM_007583] |
KLA | 1.00 |
1.08 |
1.08 |
.95 |
1.07 |
1.09 |
1.03 |
| ATP | 1.04 |
1.05 |
1.05 |
1.04 |
1.00 |
1.02 |
.99 |
| KLA/ATP | 1.00 |
.98 |
1.02 |
1.09 |
1.06 |
1.07 |
1.03 |
|
Cacng3 | |
NM_019430 |
calcium channel, voltage-dependent, gamma subunit 3 (Cacng3), mRNA [NM_019430] |
KLA | 1.07 |
1.09 |
1.00 |
.97 |
1.01 |
.94 |
.89 |
| ATP | 1.06 |
1.11 |
1.07 |
1.00 |
.98 |
.99 |
.97 |
| KLA/ATP | 1.07 |
1.06 |
1.03 |
.94 |
1.00 |
.99 |
.95 |
|
Cacng4 | |
AJ272045 |
mRNA for calcium channel gamma 4 subunit (CACNG4 gene) [AJ272045] |
KLA | .99 |
.95 |
1.01 |
1.02 |
.98 |
1.09 |
.92 |
| ATP | .96 |
1.09 |
1.00 |
.95 |
.97 |
1.06 |
.95 |
| KLA/ATP | .97 |
1.01 |
1.04 |
.97 |
1.00 |
.96 |
.98 |
|
Cacng5 | |
NM_080644 |
calcium channel, voltage-dependent, gamma subunit 5 (Cacng5), mRNA [NM_080644] |
KLA | .98 |
.99 |
.91 |
.98 |
1.02 |
.98 |
.98 |
| ATP | .96 |
1.02 |
.99 |
.99 |
1.05 |
1.04 |
.95 |
| KLA/ATP | .95 |
1.01 |
1.07 |
.99 |
1.02 |
.95 |
.99 |
|
Cacng6 | |
NM_133183 |
calcium channel, voltage-dependent, gamma subunit 6 (Cacng6), mRNA [NM_133183] |
KLA | .95 |
.95 |
.94 |
1.03 |
.94 |
1.09 |
1.14 |
| ATP | 1.00 |
1.05 |
.95 |
1.05 |
.94 |
.93 |
.99 |
| KLA/ATP | 1.02 |
.98 |
.92 |
.97 |
1.02 |
.96 |
1.05 |
|
Cacng7 | |
NM_133189 |
calcium channel, voltage-dependent, gamma subunit 7 (Cacng7), mRNA [NM_133189] |
KLA | 1.01 |
1.04 |
.98 |
1.01 |
1.00 |
1.05 |
1.02 |
| ATP | 1.05 |
1.03 |
.99 |
1.00 |
.98 |
.95 |
.98 |
| KLA/ATP | 1.00 |
.98 |
1.07 |
.99 |
.97 |
1.03 |
1.01 |
|
Cacng8 | |
NM_133190 |
calcium channel, voltage-dependent, gamma subunit 8 (Cacng8), mRNA [NM_133190] |
KLA | 1.17 |
1.16 |
1.20 |
1.31 |
1.16 |
1.13 |
1.09 |
| ATP | .98 |
1.09 |
1.06 |
1.06 |
1.03 |
1.18 |
.99 |
| KLA/ATP | 1.27 |
1.35 |
1.29 |
1.09 |
1.04 |
1.06 |
1.19 |
|
Cox4i1 | |
NM_009941 |
cytochrome c oxidase subunit IV isoform 1 (Cox4i1), mRNA [NM_009941] |
KLA | .94 |
.92 |
.88 |
1.05 |
1.00 |
.86 |
.85 |
| ATP | 1.02 |
1.01 |
1.03 |
1.06 |
1.15 |
1.18 |
.91 |
| KLA/ATP | 1.05 |
1.01 |
1.12 |
1.05 |
.99 |
1.07 |
1.02 |
|
Cox4i2 | |
NM_053091 |
cytochrome c oxidase subunit IV isoform 2 (Cox4i2), nuclear gene encoding mitochondrial protein, mRNA [NM_053091] |
KLA | 1.10 |
.97 |
1.01 |
1.05 |
1.10 |
1.15 |
1.47 |
| ATP | .99 |
1.00 |
.98 |
.95 |
1.01 |
1.10 |
1.06 |
| KLA/ATP | 1.06 |
1.05 |
1.08 |
.94 |
1.03 |
1.01 |
1.20 |
|
Cox5a | |
NM_007747 |
cytochrome c oxidase, subunit Va (Cox5a), nuclear gene encoding mitochondrial protein, mRNA [NM_007747] |
KLA | 1.45 |
1.31 |
1.22 |
1.31 |
1.35 |
1.54 |
1.90 |
| ATP | .98 |
.98 |
1.08 |
.97 |
1.06 |
1.24 |
1.11 |
| KLA/ATP | 1.11 |
1.27 |
1.38 |
1.29 |
1.36 |
1.54 |
1.48 |
|
Cox5b | |
NM_009942 |
cytochrome c oxidase, subunit Vb (Cox5b), mRNA [NM_009942] |
KLA | 1.02 |
.96 |
.93 |
.98 |
.98 |
1.10 |
1.09 |
| ATP | .92 |
1.01 |
1.08 |
1.17 |
1.01 |
1.05 |
1.08 |
| KLA/ATP | .94 |
1.03 |
1.08 |
1.23 |
1.18 |
1.30 |
1.19 |
|
Cox6a1 | |
NM_007748 |
cytochrome c oxidase, subunit VI a, polypeptide 1 (Cox6a1), nuclear gene encoding mitochondrial protein, mRNA [NM_007748] |
KLA | .93 |
.94 |
.90 |
.98 |
.95 |
1.01 |
1.03 |
| ATP | .93 |
.91 |
1.03 |
.89 |
.86 |
.88 |
.82 |
| KLA/ATP | .98 |
.83 |
1.08 |
1.06 |
.96 |
.81 |
.79 |
|
Cox6a2 | |
NM_009943 |
cytochrome c oxidase, subunit VI a, polypeptide 2 (Cox6a2), nuclear gene encoding mitochondrial protein, mRNA [NM_009943] |
KLA | 1.12 |
1.15 |
1.13 |
1.37 |
2.13 |
3.23 |
3.70 |
| ATP | 1.02 |
.99 |
1.31 |
1.51 |
1.15 |
.69 |
1.13 |
| KLA/ATP | 1.01 |
1.21 |
1.40 |
1.46 |
1.17 |
1.00 |
1.89 |
|
Cox6b1 | |
NM_025628 |
cytochrome c oxidase, subunit VIb polypeptide 1 (Cox6b1), mRNA [NM_025628] |
KLA | 1.28 |
1.19 |
1.23 |
1.20 |
1.23 |
1.33 |
1.13 |
| ATP | .89 |
1.05 |
1.22 |
1.48 |
1.35 |
1.33 |
.93 |
| KLA/ATP | 1.28 |
1.39 |
1.48 |
1.91 |
1.50 |
1.65 |
1.25 |
|
Cox6b2 | |
NM_183405 |
cytochrome c oxidase subunit VIb polypeptide 2 (Cox6b2), mRNA [NM_183405] |
KLA | 1.74 |
1.90 |
2.21 |
2.20 |
2.20 |
2.21 |
1.17 |
| ATP | 1.01 |
1.01 |
1.20 |
1.47 |
1.39 |
1.37 |
1.06 |
| KLA/ATP | 1.86 |
1.94 |
2.28 |
2.62 |
2.56 |
2.12 |
1.80 |
|
Cox6c | |
NM_053071 |
cytochrome c oxidase, subunit VIc (Cox6c), mRNA [NM_053071] |
KLA | 1.13 |
1.05 |
1.01 |
1.38 |
1.02 |
.85 |
.90 |
| ATP | 1.01 |
.89 |
1.23 |
1.09 |
1.26 |
1.24 |
.80 |
| KLA/ATP | 1.01 |
1.08 |
1.66 |
1.12 |
1.34 |
1.19 |
.89 |
|
Cox7a1 | |
NM_009944 |
cytochrome c oxidase, subunit VIIa 1 (Cox7a1), mRNA [NM_009944] |
KLA | 1.12 |
1.10 |
1.03 |
1.03 |
.90 |
.78 |
.36 |
| ATP | 1.00 |
1.02 |
1.27 |
1.53 |
1.25 |
1.06 |
.66 |
| KLA/ATP | 1.17 |
1.14 |
1.48 |
1.53 |
1.40 |
1.04 |
.66 |
|
Cox7a2 | |
NM_009945 |
cytochrome c oxidase, subunit VIIa 2 (Cox7a2), mRNA [NM_009945] |
KLA | 1.10 |
1.03 |
.99 |
1.12 |
1.02 |
1.05 |
.99 |
| ATP | .99 |
.97 |
1.34 |
1.18 |
1.17 |
1.42 |
.85 |
| KLA/ATP | .98 |
1.05 |
1.45 |
1.34 |
1.38 |
1.50 |
1.08 |
|
Cox7a2l | |
NM_009187 |
cytochrome c oxidase subunit VIIa polypeptide 2-like (Cox7a2l), nuclear gene encoding mitochondrial protein, mRNA [NM_009187] |
KLA | .84 |
.87 |
.83 |
.75 |
.81 |
.77 |
.88 |
| ATP | .98 |
1.02 |
.99 |
1.23 |
1.01 |
.73 |
.52 |
| KLA/ATP | .85 |
.86 |
.84 |
.98 |
.83 |
.75 |
.72 |
|
Cox7b | |
NM_025379 |
cytochrome c oxidase subunit VIIb (Cox7b), nuclear gene encoding mitochondrial protein, mRNA [NM_025379] |
KLA | 1.00 |
.91 |
.98 |
.97 |
.97 |
.91 |
.92 |
| ATP | 1.06 |
1.12 |
1.35 |
1.42 |
1.21 |
1.06 |
.78 |
| KLA/ATP | 1.13 |
1.07 |
1.26 |
1.41 |
1.18 |
1.06 |
.91 |
|
Cox7b2 | |
NM_030052 |
cytochrome c oxidase subunit VIIb2 (Cox7b2), mRNA [NM_030052] |
KLA | 1.03 |
1.07 |
.98 |
1.02 |
1.03 |
1.04 |
.95 |
| ATP | .97 |
1.00 |
1.04 |
.97 |
1.04 |
.99 |
1.01 |
| KLA/ATP | .95 |
.96 |
1.02 |
.97 |
1.06 |
1.05 |
.99 |
|
Cox7c | |
NM_007749 |
cytochrome c oxidase, subunit VIIc (Cox7c), nuclear gene encoding mitochondrial protein, mRNA [NM_007749] |
KLA | 1.38 |
1.24 |
1.08 |
1.42 |
1.21 |
1.05 |
1.06 |
| ATP | 1.03 |
1.05 |
1.34 |
1.43 |
1.33 |
1.13 |
.77 |
| KLA/ATP | 1.16 |
1.32 |
1.73 |
1.81 |
1.60 |
1.55 |
1.03 |
|
Cox8a | |
NM_007750 |
cytochrome c oxidase, subunit VIIIa (Cox8a), mRNA [NM_007750] |
KLA | .91 |
.91 |
.96 |
1.02 |
1.01 |
.98 |
1.19 |
| ATP | 1.07 |
1.05 |
1.03 |
1.22 |
1.11 |
.97 |
.85 |
| KLA/ATP | .98 |
1.02 |
1.10 |
1.14 |
1.21 |
.97 |
.90 |
|
Cox8b | |
NM_007751 |
cytochrome c oxidase, subunit VIIIb (Cox8b), nuclear gene encoding mitochondrial protein, mRNA [NM_007751] |
KLA | .98 |
1.03 |
.99 |
.98 |
1.06 |
1.05 |
1.03 |
| ATP | 1.01 |
.99 |
.91 |
1.09 |
1.06 |
.98 |
.99 |
| KLA/ATP | 1.07 |
1.02 |
.86 |
1.03 |
1.06 |
1.04 |
1.00 |
|
Cox8c | |
NM_001039049 |
cytochrome c oxidase, subunit VIIIc (Cox8c), nuclear gene encoding mitochondrial protein, mRNA [NM_001039049] |
KLA | .97 |
1.03 |
1.05 |
1.05 |
1.00 |
1.03 |
1.03 |
| ATP | 1.06 |
1.04 |
1.04 |
1.02 |
.95 |
1.06 |
1.01 |
| KLA/ATP | 1.04 |
1.01 |
1.01 |
1.03 |
1.00 |
1.16 |
.98 |
|
Cyc1 | |
NM_025567 |
cytochrome c-1 (Cyc1), mRNA [NM_025567] |
KLA | 1.02 |
1.01 |
1.02 |
.89 |
1.07 |
1.03 |
1.22 |
| ATP | 1.11 |
1.23 |
1.08 |
1.20 |
1.16 |
.87 |
1.09 |
| KLA/ATP | 1.15 |
1.07 |
.97 |
1.22 |
.91 |
.94 |
1.12 |
|
Fxyd2 | |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
Mm.19666 8 | |
118131189 |
Unknown |
KLA | 1.18 |
1.14 |
1.10 |
1.18 |
1.17 |
1.29 |
1.16 |
| ATP | 1.01 |
.95 |
1.10 |
1.17 |
1.10 |
1.04 |
1.08 |
| KLA/ATP | 1.19 |
1.15 |
1.34 |
1.29 |
1.33 |
1.17 |
1.24 |
|
Mm.21499 4 | |
148540002 |
Unknown |
KLA | 1.04 |
1.08 |
1.14 |
1.05 |
1.07 |
1.18 |
1.23 |
| ATP | 1.02 |
.99 |
1.08 |
1.05 |
1.00 |
1.01 |
1.01 |
| KLA/ATP | 1.02 |
1.11 |
1.10 |
.99 |
1.03 |
1.10 |
1.11 |
|
Mm.29512 4 | |
47894397 |
Unknown |
KLA | 2.28 |
2.33 |
2.46 |
2.01 |
2.46 |
1.89 |
.67 |
| ATP | 1.01 |
1.07 |
.89 |
.84 |
.86 |
1.54 |
.78 |
| KLA/ATP | 2.15 |
2.39 |
1.74 |
1.93 |
1.46 |
1.24 |
.66 |
|
Mm.29625
| |
34536833 |
Unknown |
KLA | 1.02 |
.99 |
1.07 |
.90 |
1.01 |
1.14 |
1.01 |
| ATP | 1.07 |
1.16 |
1.05 |
1.04 |
.93 |
.98 |
1.06 |
| KLA/ATP | .98 |
1.04 |
1.04 |
1.06 |
.93 |
.96 |
1.04 |
|
Mm.35799 0 | |
21687185 |
Unknown |
KLA | 1.18 |
1.20 |
1.19 |
1.23 |
1.18 |
1.19 |
1.10 |
| ATP | .97 |
1.07 |
1.11 |
1.19 |
1.01 |
1.15 |
.98 |
| KLA/ATP | 1.06 |
1.29 |
1.19 |
1.29 |
1.19 |
1.10 |
1.10 |
|
Mm.37889 8 | |
93102385 |
Unknown |
KLA | 1.07 |
.94 |
.91 |
1.12 |
1.00 |
1.03 |
.96 |
| ATP | 1.08 |
1.00 |
1.10 |
.94 |
1.00 |
1.02 |
.67 |
| KLA/ATP | .96 |
.94 |
1.29 |
1.07 |
1.14 |
1.08 |
.72 |
|
Mm.42303 0 | |
83816960 |
Unknown |
KLA | 1.23 |
1.10 |
1.00 |
1.14 |
.91 |
.86 |
.42 |
| ATP | .86 |
.92 |
1.32 |
1.42 |
1.14 |
1.18 |
.74 |
| KLA/ATP | 1.03 |
1.20 |
1.48 |
1.56 |
1.48 |
1.11 |
.79 |
|
Mm.44077 3 | |
124517717 |
Unknown |
KLA | .69 |
.69 |
.71 |
.76 |
.71 |
.73 |
.58 |
| ATP | .93 |
.96 |
1.01 |
.85 |
.73 |
.76 |
.57 |
| KLA/ATP | .60 |
.65 |
.75 |
.80 |
.76 |
.66 |
.55 |
|
Mm.44591 2 | |
9506452 |
Unknown |
KLA | .98 |
.99 |
1.00 |
1.07 |
.99 |
.98 |
1.07 |
| ATP | 1.02 |
1.05 |
.94 |
.96 |
1.01 |
1.00 |
.94 |
| KLA/ATP | 1.01 |
1.08 |
1.04 |
.92 |
.92 |
1.00 |
1.03 |
|
Mm.45798 3 | |
118131045 |
Unknown |
KLA | .95 |
1.08 |
1.17 |
1.13 |
1.10 |
1.13 |
1.06 |
| ATP | 1.02 |
.97 |
1.03 |
1.07 |
1.17 |
1.22 |
1.05 |
| KLA/ATP | 1.04 |
1.05 |
1.06 |
1.11 |
1.41 |
1.49 |
1.08 |
|
Mm.46359 0 | |
21687181 |
Unknown |
KLA | .76 |
.80 |
.87 |
.99 |
.94 |
1.02 |
.98 |
| ATP | .90 |
.94 |
1.06 |
.97 |
.83 |
.93 |
.85 |
| KLA/ATP | .79 |
.91 |
.98 |
1.01 |
.97 |
.84 |
.78 |
|
Mm.87663
| |
142370454 |
Unknown |
KLA | 1.04 |
1.01 |
1.01 |
1.10 |
.95 |
1.04 |
.95 |
| ATP | .96 |
1.01 |
.96 |
.98 |
.94 |
1.05 |
1.12 |
| KLA/ATP | .98 |
.97 |
1.12 |
1.03 |
1.06 |
.94 |
1.02 |
|
Myh6 | |
NM_010856 |
myosin, heavy polypeptide 6, cardiac muscle, alpha (Myh6), mRNA [NM_010856] |
KLA | 1.00 |
1.01 |
1.00 |
.99 |
1.00 |
.98 |
1.02 |
| ATP | 1.00 |
.99 |
.96 |
.98 |
1.01 |
1.01 |
.98 |
| KLA/ATP | 1.03 |
1.04 |
1.01 |
1.01 |
.99 |
1.00 |
1.02 |
|
Myh7 | |
NM_080728 |
myosin, heavy polypeptide 7, cardiac muscle, beta (Myh7), mRNA [NM_080728] |
KLA | 1.06 |
1.13 |
1.14 |
1.07 |
1.09 |
1.06 |
1.03 |
| ATP | .96 |
1.01 |
1.09 |
1.05 |
1.15 |
1.16 |
1.12 |
| KLA/ATP | 1.01 |
1.05 |
1.02 |
.98 |
1.29 |
1.62 |
1.09 |
|
Myl2 | |
NM_010861 |
myosin, light polypeptide 2, regulatory, cardiac, slow (Myl2), mRNA [NM_010861] |
KLA | .88 |
.93 |
.94 |
.95 |
.94 |
.77 |
.60 |
| ATP | .96 |
1.04 |
1.14 |
1.06 |
1.00 |
.93 |
.66 |
| KLA/ATP | .91 |
.85 |
1.07 |
1.03 |
.88 |
.79 |
.67 |
|
Myl3 | |
NM_010859 |
myosin, light polypeptide 3 (Myl3), mRNA [NM_010859] |
KLA | 1.08 |
1.10 |
1.14 |
1.11 |
1.15 |
1.25 |
1.14 |
| ATP | 1.00 |
1.08 |
1.19 |
1.24 |
1.17 |
1.16 |
1.03 |
| KLA/ATP | 1.16 |
1.17 |
1.18 |
1.28 |
1.21 |
1.23 |
1.14 |
|
Ryr2 | |
BC043140 |
ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] |
KLA | .97 |
1.03 |
1.01 |
1.03 |
1.03 |
1.01 |
1.05 |
| ATP | .99 |
.98 |
1.03 |
1.02 |
1.01 |
1.09 |
1.04 |
| KLA/ATP | .98 |
1.00 |
.98 |
1.04 |
1.04 |
1.06 |
1.00 |
|
Ryr2 | |
NM_023868 |
ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] |
KLA | 1.04 |
1.02 |
1.00 |
1.00 |
1.03 |
.97 |
.96 |
| ATP | .95 |
1.04 |
1.00 |
.94 |
.98 |
1.01 |
1.08 |
| KLA/ATP | .99 |
.97 |
1.02 |
1.03 |
1.00 |
.98 |
1.00 |
|
Slc8a1 | |
AF004666 |
sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] |
KLA | 1.13 |
1.10 |
1.22 |
1.44 |
1.52 |
1.55 |
1.10 |
| ATP | 1.03 |
1.05 |
1.22 |
1.12 |
.65 |
.49 |
.67 |
| KLA/ATP | 1.04 |
1.21 |
1.30 |
1.44 |
.81 |
.63 |
1.01 |
|
Slc8a1 | |
AF108396 |
sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] |
KLA | 1.07 |
1.18 |
1.30 |
1.22 |
1.31 |
1.39 |
1.21 |
| ATP | 1.03 |
1.02 |
1.10 |
1.07 |
.88 |
.91 |
1.23 |
| KLA/ATP | 1.15 |
1.17 |
1.14 |
1.22 |
.96 |
1.01 |
1.77 |
|
Slc8a1 | |
NM_011406 |
solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] |
KLA | 1.12 |
1.16 |
1.22 |
1.25 |
1.35 |
1.33 |
1.11 |
| ATP | 1.03 |
1.04 |
1.07 |
1.10 |
.93 |
.90 |
1.19 |
| KLA/ATP | 1.13 |
1.24 |
1.19 |
1.16 |
.93 |
1.06 |
1.62 |
|
Slc9a1 | |
NM_016981 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 (Slc9a1), mRNA [NM_016981] |
KLA | 1.74 |
1.72 |
1.95 |
1.84 |
1.86 |
1.53 |
1.49 |
| ATP | 1.11 |
1.28 |
.95 |
1.46 |
1.98 |
2.67 |
1.47 |
| KLA/ATP | 1.85 |
2.02 |
1.70 |
2.47 |
2.18 |
3.18 |
3.48 |
|
Slc9a1 | |
U51112 |
Na+/H+ exchanger (NHE-1) mRNA, complete cds. [U51112] |
KLA | 1.78 |
1.83 |
2.11 |
1.90 |
1.91 |
1.61 |
1.40 |
| ATP | 1.07 |
1.14 |
.98 |
1.54 |
2.00 |
2.85 |
1.44 |
| KLA/ATP | 1.97 |
2.16 |
2.01 |
2.44 |
2.30 |
3.37 |
3.15 |
|
Slc9a6 | |
AK122232 |
mRNA for mKIAA0267 protein [AK122232] |
KLA | .80 |
.79 |
.76 |
.70 |
.64 |
.66 |
.81 |
| ATP | 1.01 |
1.04 |
1.03 |
.87 |
.72 |
.70 |
.77 |
| KLA/ATP | .80 |
.81 |
.68 |
.64 |
.55 |
.47 |
.47 |
|
Slc9a6 | |
NM_172780 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 (Slc9a6), mRNA [NM_172780] |
KLA | .83 |
.91 |
.85 |
.82 |
.81 |
.92 |
.99 |
| ATP | .96 |
1.03 |
1.11 |
1.01 |
.93 |
1.13 |
1.85 |
| KLA/ATP | .87 |
.91 |
.85 |
.83 |
.84 |
.97 |
1.55 |
|
Tnnc1 | |
NM_009393 |
troponin C, cardiac/slow skeletal (Tnnc1), mRNA [NM_009393] |
KLA | .52 |
.57 |
.60 |
.71 |
.91 |
1.03 |
1.71 |
| ATP | .92 |
.70 |
.67 |
.76 |
1.70 |
1.56 |
4.25 |
| KLA/ATP | .57 |
.55 |
.60 |
.66 |
1.03 |
.86 |
2.98 |
|
Tnni3 | |
NM_009406 |
troponin I, cardiac (Tnni3), mRNA [NM_009406] |
KLA | 2.51 |
2.58 |
2.65 |
2.15 |
2.99 |
3.24 |
2.22 |
| ATP | 1.06 |
1.04 |
1.00 |
1.06 |
.69 |
.91 |
.68 |
| KLA/ATP | 2.78 |
2.94 |
2.75 |
2.10 |
1.22 |
1.46 |
1.67 |
|
Tnnt2 | |
AK086260 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930016O21 product:troponin T2, cardiac, full insert sequence [AK086260] |
KLA | 1.03 |
1.00 |
.97 |
.99 |
1.01 |
.96 |
1.01 |
| ATP | .97 |
1.08 |
.91 |
.97 |
.96 |
1.10 |
1.03 |
| KLA/ATP | .99 |
1.01 |
1.07 |
.97 |
1.00 |
1.01 |
1.09 |
|
Tnnt2 | |
NM_011619 |
troponin T2, cardiac (Tnnt2), mRNA [NM_011619] |
KLA | 1.01 |
1.03 |
1.05 |
1.07 |
1.04 |
1.00 |
.99 |
| ATP | .97 |
.97 |
1.04 |
1.07 |
.96 |
.99 |
1.06 |
| KLA/ATP | 1.11 |
1.12 |
1.04 |
1.03 |
.98 |
1.02 |
1.04 |
|
Tpm1 | |
NM_024427 |
tropomyosin 1, alpha (Tpm1), mRNA [NM_024427] |
KLA | .89 |
.89 |
.84 |
.57 |
.52 |
.63 |
.73 |
| ATP | 1.01 |
1.03 |
1.00 |
1.10 |
1.86 |
1.03 |
1.48 |
| KLA/ATP | .96 |
.89 |
.81 |
.76 |
1.00 |
.89 |
1.11 |
|
Tpm2 | |
NM_009416 |
tropomyosin 2, beta (Tpm2), mRNA [NM_009416] |
KLA | .97 |
1.09 |
.97 |
.96 |
1.01 |
1.05 |
.86 |
| ATP | 1.04 |
1.02 |
1.09 |
1.12 |
1.04 |
.98 |
.83 |
| KLA/ATP | 1.07 |
1.15 |
1.10 |
1.16 |
1.06 |
.90 |
.83 |
|
Tpm3 | |
NM_022314 |
tropomyosin 3, gamma (Tpm3), mRNA [NM_022314] |
KLA | 1.24 |
1.34 |
1.32 |
1.37 |
1.58 |
1.38 |
1.21 |
| ATP | 1.11 |
1.25 |
.97 |
1.43 |
1.09 |
.80 |
1.10 |
| KLA/ATP | 1.43 |
1.65 |
1.10 |
1.73 |
1.02 |
1.06 |
1.55 |
|
Tpm4 | |
NM_001001491 |
tropomyosin 4 (Tpm4), mRNA [NM_001001491] |
KLA | 2.08 |
2.02 |
2.44 |
2.21 |
2.15 |
1.91 |
.69 |
| ATP | 1.03 |
.97 |
.97 |
.84 |
.97 |
1.75 |
.77 |
| KLA/ATP | 2.12 |
2.08 |
2.20 |
1.78 |
1.71 |
1.33 |
.69 |
|
Uqcr | |
NM_025650 |
ubiquinol-cytochrome c reductase (6.4kD) subunit (Uqcr), mRNA [NM_025650] |
KLA | .88 |
.78 |
.82 |
.91 |
.72 |
.69 |
.63 |
| ATP | 1.13 |
1.03 |
1.18 |
1.31 |
1.15 |
1.02 |
.78 |
| KLA/ATP | .92 |
.91 |
1.05 |
1.08 |
1.03 |
.85 |
.61 |
|
Uqcrb | |
NM_026219 |
ubiquinol-cytochrome c reductase binding protein (Uqcrb), nuclear gene encoding mitochondrial protein, mRNA [NM_026219] |
KLA | 1.06 |
.95 |
.99 |
1.09 |
1.01 |
1.11 |
.98 |
| ATP | 1.08 |
.97 |
1.35 |
1.07 |
1.19 |
1.14 |
.99 |
| KLA/ATP | 1.05 |
.98 |
1.49 |
1.22 |
1.30 |
1.24 |
.92 |
|
Uqcrc1 | |
NM_025407 |
ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1), mRNA [NM_025407] |
KLA | .90 |
.96 |
.94 |
.90 |
.89 |
.85 |
.92 |
| ATP | .97 |
1.06 |
.95 |
1.10 |
.92 |
.73 |
.89 |
| KLA/ATP | .94 |
.99 |
.89 |
1.01 |
.85 |
.78 |
.73 |
|
Uqcrc2 | |
NM_025899 |
ubiquinol cytochrome c reductase core protein 2 (Uqcrc2), mRNA [NM_025899] |
KLA | 1.00 |
1.08 |
1.05 |
1.10 |
1.03 |
1.08 |
1.06 |
| ATP | .91 |
.89 |
1.17 |
.95 |
.96 |
.88 |
.97 |
| KLA/ATP | .95 |
.96 |
1.26 |
1.00 |
1.07 |
.97 |
.92 |
|
Uqcrfs1 | |
NM_025710 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (Uqcrfs1), mRNA [NM_025710] |
KLA | 1.21 |
1.17 |
1.22 |
1.37 |
1.08 |
.92 |
.87 |
| ATP | .91 |
.87 |
1.28 |
1.14 |
.97 |
1.00 |
.82 |
| KLA/ATP | 1.04 |
1.07 |
1.52 |
1.35 |
1.17 |
.91 |
.77 |
|
Uqcrh | |
NM_025641 |
ubiquinol-cytochrome c reductase hinge protein (Uqcrh), mRNA [NM_025641] |
KLA | .94 |
1.04 |
1.09 |
1.06 |
.95 |
.94 |
.90 |
| ATP | .95 |
.90 |
1.19 |
1.06 |
1.10 |
1.18 |
.86 |
| KLA/ATP | 1.02 |
1.01 |
1.34 |
1.19 |
1.36 |
1.28 |
.90 |
|
Uqcrq | |
AK017907 |
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830407L17 product:Ubiquinol-cytochrome c reductase binding protein, full insert sequence. [AK017907] |
KLA | .95 |
.93 |
.98 |
1.02 |
1.07 |
1.14 |
1.21 |
| ATP | .73 |
.82 |
.80 |
.99 |
1.08 |
.96 |
1.08 |
| KLA/ATP | .81 |
.86 |
.85 |
.97 |
.94 |
1.02 |
.98 |
|
Uqcrq | |
NM_025352 |
ubiquinol-cytochrome c reductase, complex III subunit VII (Uqcrq), nuclear gene encoding mitochondrial protein, mRNA [NM_025352] |
KLA | .97 |
.92 |
.86 |
.94 |
.89 |
1.02 |
1.25 |
| ATP | .90 |
.84 |
1.11 |
1.04 |
1.07 |
1.00 |
.97 |
| KLA/ATP | .83 |
.87 |
1.15 |
1.01 |
1.14 |
1.06 |
.89 |
|